Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...

What seemed like a simple illness turned into a life-changing diagnosis for Debi Weiss, a 72-year-old Pilates instructor who later discovered she had an aggressive form of cancer. Her journey through ...

Giahan Tang thought she was finally finding stability after college when unusual symptoms led to a shock diagnosis of stage 4 diffuse large B-cell lymphoma After an ER visit initially blamed on an ...

Real-time ctDNA MRD testing guides early chemo de-escalation in diffuse large B-cell lymphoma, aiming to cut toxicity without losing cure rates. In an interview with Targeted Oncology, Hua-Jay “Jeff” ...

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

Gilead plans a $7.8B Arcellx acquisition as cell therapy sales decline, seeking full control of anito-cel to strengthen its oncology pipeline.

HealthDay News — Features that characterize presentation of vitreoretinal lymphoma are described in an article published online March 1 in Clinical & Experimental Ophthalmology.

Operator: Hello, and thank you for standing by. Welcome to Allogene Therapeutics, Inc. Fourth Quarter 2025 Conference Call.

Abstract: The channel state information (CSI) acquisition plays a pivotal role in cell-free (CF) massive multiple-input-multi-output (mMIMO) systems. However, conventional pilot-based channel ...

Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and palliative care.

Pivotal, Randomized Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in ...

Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal ...